IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $12,191,000 | +128.8% | 143,377 | -4.6% | 0.03% | +113.3% |
Q2 2020 | $5,329,000 | +143.4% | 150,359 | -7.4% | 0.02% | +87.5% |
Q1 2020 | $2,189,000 | -60.4% | 162,375 | -37.9% | 0.01% | -52.9% |
Q4 2019 | $5,532,000 | +59.6% | 261,455 | 0.0% | 0.02% | +54.5% |
Q3 2019 | $3,467,000 | +3.1% | 261,455 | +7.8% | 0.01% | 0.0% |
Q2 2019 | $3,364,000 | -25.1% | 242,528 | +3.7% | 0.01% | -31.2% |
Q1 2019 | $4,492,000 | +43.2% | 233,856 | +1.8% | 0.02% | +23.1% |
Q4 2018 | $3,137,000 | -30.6% | 229,721 | +5.8% | 0.01% | -23.5% |
Q3 2018 | $4,521,000 | -11.7% | 217,063 | -0.1% | 0.02% | -15.0% |
Q2 2018 | $5,120,000 | +71.1% | 217,241 | +6.1% | 0.02% | +66.7% |
Q1 2018 | $2,992,000 | -13.2% | 204,781 | -4.0% | 0.01% | -20.0% |
Q4 2017 | $3,447,000 | -86.8% | 213,295 | -88.6% | 0.02% | -87.7% |
Q3 2017 | $26,168,000 | +1554.1% | 1,871,847 | +945.0% | 0.12% | +1425.0% |
Q2 2017 | $1,582,000 | +38.9% | 179,130 | +1.7% | 0.01% | +33.3% |
Q1 2017 | $1,139,000 | +364.9% | 176,065 | +163.3% | 0.01% | +500.0% |
Q4 2016 | $245,000 | +28.9% | 66,865 | +14.3% | 0.00% | 0.0% |
Q3 2016 | $190,000 | +39.7% | 58,485 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $136,000 | -6.2% | 58,485 | +0.9% | 0.00% | 0.0% |
Q1 2016 | $145,000 | -34.4% | 57,975 | -19.5% | 0.00% | -50.0% |
Q4 2015 | $221,000 | +245.3% | 71,975 | +94.7% | 0.00% | +100.0% |
Q3 2015 | $64,000 | -57.0% | 36,975 | +0.5% | 0.00% | 0.0% |
Q2 2015 | $149,000 | +12.0% | 36,800 | +5.7% | 0.00% | 0.0% |
Q1 2015 | $133,000 | -10.1% | 34,800 | +13.0% | 0.00% | -50.0% |
Q4 2014 | $148,000 | +31.0% | 30,800 | +1.7% | 0.00% | +100.0% |
Q3 2014 | $113,000 | +5.6% | 30,300 | +3.4% | 0.00% | 0.0% |
Q2 2014 | $107,000 | -4.5% | 29,300 | +10.2% | 0.00% | -50.0% |
Q1 2014 | $112,000 | +366.7% | 26,590 | +402.6% | 0.00% | – |
Q4 2013 | $24,000 | -27.3% | 5,290 | 0.0% | 0.00% | -100.0% |
Q3 2013 | $33,000 | +13.8% | 5,290 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $29,000 | – | 5,290 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |